Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by General Anaesthesia Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global General Anaesthesia Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Propofol 1.4.3 Sevoflurane 1.4.4 Isoflurane 1.4.5 Dexmedetomidine 1.4.6 Desflurane 1.4.7 Remifentanil 1.4.8 Midazolam 1.4.9 Others 1.5 Market by Application 1.5.1 Global General Anaesthesia Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 General Anaesthesia Drugs Market Perspective (2015-2026) 2.2 General Anaesthesia Drugs Growth Trends by Regions 2.2.1 General Anaesthesia Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 General Anaesthesia Drugs Historic Market Share by Regions (2015-2020) 2.2.3 General Anaesthesia Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 General Anaesthesia Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key General Anaesthesia Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top General Anaesthesia Drugs Players by Market Size 3.1.1 Global Top General Anaesthesia Drugs Players by Revenue (2015-2020) 3.1.2 Global General Anaesthesia Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global General Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global General Anaesthesia Drugs Market Concentration Ratio 3.2.1 Global General Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by General Anaesthesia Drugs Revenue in 2019 3.3 General Anaesthesia Drugs Key Players Head office and Area Served 3.4 Key Players General Anaesthesia Drugs Product Solution and Service 3.5 Date of Enter into General Anaesthesia Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global General Anaesthesia Drugs Historic Market Size by Type (2015-2020) 4.2 Global General Anaesthesia Drugs Forecasted Market Size by Type (2021-2026) 5 General Anaesthesia Drugs Breakdown Data by Application (2015-2026) 5.1 Global General Anaesthesia Drugs Market Size by Application (2015-2020) 5.2 Global General Anaesthesia Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America General Anaesthesia Drugs Market Size (2015-2020) 6.2 General Anaesthesia Drugs Key Players in North America (2019-2020) 6.3 North America General Anaesthesia Drugs Market Size by Type (2015-2020) 6.4 North America General Anaesthesia Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe General Anaesthesia Drugs Market Size (2015-2020) 7.2 General Anaesthesia Drugs Key Players in Europe (2019-2020) 7.3 Europe General Anaesthesia Drugs Market Size by Type (2015-2020) 7.4 Europe General Anaesthesia Drugs Market Size by Application (2015-2020) 8 China 8.1 China General Anaesthesia Drugs Market Size (2015-2020) 8.2 General Anaesthesia Drugs Key Players in China (2019-2020) 8.3 China General Anaesthesia Drugs Market Size by Type (2015-2020) 8.4 China General Anaesthesia Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan General Anaesthesia Drugs Market Size (2015-2020) 9.2 General Anaesthesia Drugs Key Players in Japan (2019-2020) 9.3 Japan General Anaesthesia Drugs Market Size by Type (2015-2020) 9.4 Japan General Anaesthesia Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia General Anaesthesia Drugs Market Size (2015-2020) 10.2 General Anaesthesia Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia General Anaesthesia Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia General Anaesthesia Drugs Market Size by Application (2015-2020) 11 India 11.1 India General Anaesthesia Drugs Market Size (2015-2020) 11.2 General Anaesthesia Drugs Key Players in India (2019-2020) 11.3 India General Anaesthesia Drugs Market Size by Type (2015-2020) 11.4 India General Anaesthesia Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America General Anaesthesia Drugs Market Size (2015-2020) 12.2 General Anaesthesia Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America General Anaesthesia Drugs Market Size by Type (2015-2020) 12.4 Central & South America General Anaesthesia Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Baxter International 13.1.1 Baxter International Company Details 13.1.2 Baxter International Business Overview and Its Total Revenue 13.1.3 Baxter International General Anaesthesia Drugs Introduction 13.1.4 Baxter International Revenue in General Anaesthesia Drugs Business (2015-2020)) 13.1.5 Baxter International Recent Development 13.2 AstraZeneca 13.2.1 AstraZeneca Company Details 13.2.2 AstraZeneca Business Overview and Its Total Revenue 13.2.3 AstraZeneca General Anaesthesia Drugs Introduction 13.2.4 AstraZeneca Revenue in General Anaesthesia Drugs Business (2015-2020) 13.2.5 AstraZeneca Recent Development 13.3 Abbott Laboratories 13.3.1 Abbott Laboratories Company Details 13.3.2 Abbott Laboratories Business Overview and Its Total Revenue 13.3.3 Abbott Laboratories General Anaesthesia Drugs Introduction 13.3.4 Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2015-2020) 13.3.5 Abbott Laboratories Recent Development 13.4 Roche 13.4.1 Roche Company Details 13.4.2 Roche Business Overview and Its Total Revenue 13.4.3 Roche General Anaesthesia Drugs Introduction 13.4.4 Roche Revenue in General Anaesthesia Drugs Business (2015-2020) 13.4.5 Roche Recent Development 13.5 Fresenius 13.5.1 Fresenius Company Details 13.5.2 Fresenius Business Overview and Its Total Revenue 13.5.3 Fresenius General Anaesthesia Drugs Introduction 13.5.4 Fresenius Revenue in General Anaesthesia Drugs Business (2015-2020) 13.5.5 Fresenius Recent Development 13.6 Mylan 13.6.1 Mylan Company Details 13.6.2 Mylan Business Overview and Its Total Revenue 13.6.3 Mylan General Anaesthesia Drugs Introduction 13.6.4 Mylan Revenue in General Anaesthesia Drugs Business (2015-2020) 13.6.5 Mylan Recent Development 13.7 Eisai 13.7.1 Eisai Company Details 13.7.2 Eisai Business Overview and Its Total Revenue 13.7.3 Eisai General Anaesthesia Drugs Introduction 13.7.4 Eisai Revenue in General Anaesthesia Drugs Business (2015-2020) 13.7.5 Eisai Recent Development 13.8 Hospira 13.8.1 Hospira Company Details 13.8.2 Hospira Business Overview and Its Total Revenue 13.8.3 Hospira General Anaesthesia Drugs Introduction 13.8.4 Hospira Revenue in General Anaesthesia Drugs Business (2015-2020) 13.8.5 Hospira Recent Development 13.9 Hikma Pharmaceuticals 13.9.1 Hikma Pharmaceuticals Company Details 13.9.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Introduction 13.9.4 Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2015-2020) 13.9.5 Hikma Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. General Anaesthesia Drugs Key Market Segments Table 2. Key Players Covered: Ranking by General Anaesthesia Drugs Revenue Table 3. Ranking of Global Top General Anaesthesia Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global General Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Propofol Table 6. Key Players of Sevoflurane Table 7. Key Players of Isoflurane Table 8. Key Players of Dexmedetomidine Table 9. Key Players of Desflurane Table 10. Key Players of Remifentanil Table 11. Key Players of Midazolam Table 12. Key Players of Others Table 13. Global General Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global General Anaesthesia Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global General Anaesthesia Drugs Market Size by Regions (2015-2020) (US$ Million) Table 16. Global General Anaesthesia Drugs Market Share by Regions (2015-2020) Table 17. Global General Anaesthesia Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global General Anaesthesia Drugs Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. General Anaesthesia Drugs Market Growth Strategy Table 23. Main Points Interviewed from Key General Anaesthesia Drugs Players Table 24. Global General Anaesthesia Drugs Revenue by Players (2015-2020) (Million US$) Table 25. Global General Anaesthesia Drugs Market Share by Players (2015-2020) Table 26. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anaesthesia Drugs as of 2019) Table 27. Global General Anaesthesia Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players General Anaesthesia Drugs Product Solution and Service Table 30. Date of Enter into General Anaesthesia Drugs Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 33. Global General Anaesthesia Drugs Market Size Share by Type (2015-2020) Table 34. Global General Anaesthesia Drugs Revenue Market Share by Type (2021-2026) Table 35. Global General Anaesthesia Drugs Market Size Share by Application (2015-2020) Table 36. Global General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 37. Global General Anaesthesia Drugs Market Size Share by Application (2021-2026) Table 38. North America Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 39. North America Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 40. North America General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 41. North America General Anaesthesia Drugs Market Share by Type (2015-2020) Table 42. North America General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 43. North America General Anaesthesia Drugs Market Share by Application (2015-2020) Table 44. Europe Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 45. Europe Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 46. Europe General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 47. Europe General Anaesthesia Drugs Market Share by Type (2015-2020) Table 48. Europe General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 49. Europe General Anaesthesia Drugs Market Share by Application (2015-2020) Table 50. China Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 51. China Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 52. China General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 53. China General Anaesthesia Drugs Market Share by Type (2015-2020) Table 54. China General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 55. China General Anaesthesia Drugs Market Share by Application (2015-2020) Table 56. Japan Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 57. Japan Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 58. Japan General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 59. Japan General Anaesthesia Drugs Market Share by Type (2015-2020) Table 60. Japan General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 61. Japan General Anaesthesia Drugs Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 64. Southeast Asia General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia General Anaesthesia Drugs Market Share by Type (2015-2020) Table 66. Southeast Asia General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia General Anaesthesia Drugs Market Share by Application (2015-2020) Table 68. India Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 69. India Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 70. India General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 71. India General Anaesthesia Drugs Market Share by Type (2015-2020) Table 72. India General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 73. India General Anaesthesia Drugs Market Share by Application (2015-2020) Table 74. Central & South America Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players General Anaesthesia Drugs Market Share (2019-2020) Table 76. Central & South America General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America General Anaesthesia Drugs Market Share by Type (2015-2020) Table 78. Central & South America General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America General Anaesthesia Drugs Market Share by Application (2015-2020) Table 80. Baxter International Company Details Table 81. Baxter International Business Overview Table 82. Baxter International Product Table 83. Baxter International Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 84. Baxter International Recent Development Table 85. AstraZeneca Company Details Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Product Table 88. AstraZeneca Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 89. AstraZeneca Recent Development Table 90. Abbott Laboratories Company Details Table 91. Abbott Laboratories Business Overview Table 92. Abbott Laboratories Product Table 93. Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 94. Abbott Laboratories Recent Development Table 95. Roche Company Details Table 96. Roche Business Overview Table 97. Roche Product Table 98. Roche Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 99. Roche Recent Development Table 100. Fresenius Company Details Table 101. Fresenius Business Overview Table 102. Fresenius Product Table 103. Fresenius Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 104. Fresenius Recent Development Table 105. Mylan Company Details Table 106. Mylan Business Overview Table 107. Mylan Product Table 108. Mylan Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 109. Mylan Recent Development Table 110. Eisai Company Details Table 111. Eisai Business Overview Table 112. Eisai Product Table 113. Eisai Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 114. Eisai Recent Development Table 115. Hospira Business Overview Table 116. Hospira Product Table 117. Hospira Company Details Table 118. Hospira Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 119. Hospira Recent Development Table 120. Hikma Pharmaceuticals Company Details Table 121. Hikma Pharmaceuticals Business Overview Table 122. Hikma Pharmaceuticals Product Table 123. Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$) Table 124. Hikma Pharmaceuticals Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global General Anaesthesia Drugs Market Share by Type: 2020 VS 2026 Figure 2. Propofol Features Figure 3. Sevoflurane Features Figure 4. Isoflurane Features Figure 5. Dexmedetomidine Features Figure 6. Desflurane Features Figure 7. Remifentanil Features Figure 8. Midazolam Features Figure 9. Others Features Figure 10. Global General Anaesthesia Drugs Market Share by Application: 2020 VS 2026 Figure 11. Hospitals Case Studies Figure 12. Clinics Case Studies Figure 13. Others Case Studies Figure 14. General Anaesthesia Drugs Report Years Considered Figure 15. Global General Anaesthesia Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 16. Global General Anaesthesia Drugs Market Share by Regions: 2020 VS 2026 Figure 17. Global General Anaesthesia Drugs Market Share by Regions (2021-2026) Figure 18. Porter's Five Forces Analysis Figure 19. Global General Anaesthesia Drugs Market Share by Players in 2019 Figure 20. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anaesthesia Drugs as of 2019 Figure 21. The Top 10 and 5 Players Market Share by General Anaesthesia Drugs Revenue in 2019 Figure 22. North America General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Europe General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. China General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Japan General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Southeast Asia General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 27. India General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Central & South America General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Baxter International Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. AstraZeneca Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 33. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Abbott Laboratories Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Roche Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 37. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Fresenius Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Mylan Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 41. Eisai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Eisai Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 43. Hospira Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Hospira Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 45. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Baxter International AstraZeneca Abbott Laboratories Roche Fresenius Mylan Eisai Hospira Hikma Pharmaceuticals